Altimmune stock spikes on obesity drug data (NASDAQ:ALT)09/11/2024 atakan/iStock by way of Getty Images Altimmune (NASDAQ:ALT) shares superior on Tuesday after the corporate offered mid-stage outcomes for its obesity candidate, pemvidutide, at a European…
